Today, we have good news: our company has successfully passed the 2022 Gazelle Enterprise Certification!
According to the "Implementation Measures for Promoting the Development of High Growth Technology Enterprises in Guangzhou Development Zone, Huangpu District, Guangzhou City" (Sui Pu Ke Gui Zi [2021] No. 5), "Notice on Organizing the Application and Recognition of Gazelle Enterprises in Guangzhou Development Zone, Huangpu District, Guangzhou City in 2022" (Sui Pu Ke [2022] No. 309) and other policies and relevant regulations, after strict procedures such as enterprise application, material review, and list approval, our company has successfully passed the audit and public announcement as a participating enterprise in the certification.
The recognition of Gazelle Enterprise for three consecutive years is a great affirmation of Ruite Biotechnology's recent achievements and a powerful impetus for the company's future development. The company will make sincere efforts to strengthen research and development investment, continuously explore and advance, and promote more excellent and professional products to the market through continuous innovation in management and technology. We will work together to provide customers with higher quality products and solutions.
Guangzhou Ruite Biotechnology Co., Ltd. was established in 2003 with a registered capital of 10 million yuan. It is a high-tech enterprise integrating the research and development, production, and sales of animal blood products. Its headquarters is located at No. 3 Lanyue Road, Science City, Huangpu District, Guangzhou, and its production base is located at No. 5 Zhenhua Road, Mingzhu Industrial Park, Conghua District, Guangzhou. The company covers a total area of 15000 square meters, including a purification workshop area of 3000 square meters, equipped with advanced production equipment and testing instruments. The single batch production volume of animal serum reaches 3000 liters, with an average annual production capacity of 100000 liters. Its production process, production scale, and product quality are at the leading level in China. The company has passed ISO9001:2015 quality management system certification and bovine serum production enterprise standard certification. In recent years, it has applied for 8 invention patents and 27 utility model patents, and currently has 35 authorized patents.
Focused on the production and research and development of bovine serum for 20 years
